Market Place
Sourcing Support
EMPRESS Study Shows Giredestrant Cut Tumor Growth in Early Cancer
20 Oct 2025 //
PR NEWSWIRE
ESMO: Roche Wants Oral SERD To Benefit `All Comers`
18 Oct 2025 //
FIERCE BIOTECH
Roche Showcases Science And Cancer Care Advances At ESMO 2025
13 Oct 2025 //
GLOBENEWSWIRE
Roche Reports Phase 3 Breast Cancer Victory for Oral Serd
24 Sep 2025 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.